PubMed:25315622 / 478-765 JSONTXT

{"project":"PubMed_ArguminSci","denotations":[{"id":"T3","span":{"begin":0,"end":129},"obj":"DRI_Background"},{"id":"T4","span":{"begin":129,"end":203},"obj":"DRI_Background"},{"id":"T5","span":{"begin":203,"end":287},"obj":"DRI_Background"}],"text":"Separate groups of guinea pigs were treated during the course of 21-day ovalbumin sensitization with provinol (20 mg/kg/day, p.o.), or budesonide (1 mM by inhalation), or theophylline (10 mg/kg/day, i.p.), and with a half-dose combination of provinol+budesonide or provinol+theophylline."}

{"project":"Goldhamster2_Cellosaurus","denotations":[{"id":"T6","span":{"begin":111,"end":113},"obj":"CVCL_J923|Hybridoma|Mus musculus"},{"id":"T7","span":{"begin":215,"end":216},"obj":"CVCL_6479|Finite_cell_line|Mus musculus"}],"text":"Separate groups of guinea pigs were treated during the course of 21-day ovalbumin sensitization with provinol (20 mg/kg/day, p.o.), or budesonide (1 mM by inhalation), or theophylline (10 mg/kg/day, i.p.), and with a half-dose combination of provinol+budesonide or provinol+theophylline."}

{"project":"GoldHamster","denotations":[{"id":"T24","span":{"begin":19,"end":30},"obj":"D006168"},{"id":"T25","span":{"begin":26,"end":30},"obj":"PR:Q9W3Y4"},{"id":"T28","span":{"begin":26,"end":30},"obj":"PR:Q6PD26"},{"id":"T29","span":{"begin":26,"end":30},"obj":"PR:Q5XI31"},{"id":"T30","span":{"begin":26,"end":30},"obj":"PR:Q96S52"},{"id":"T31","span":{"begin":26,"end":30},"obj":"PR:000012706"},{"id":"T32","span":{"begin":72,"end":81},"obj":"PR:000025876"},{"id":"T33","span":{"begin":72,"end":81},"obj":"E2RVI8"},{"id":"T34","span":{"begin":72,"end":81},"obj":"P19104"},{"id":"T35","span":{"begin":72,"end":81},"obj":"P01012"},{"id":"T38","span":{"begin":72,"end":81},"obj":"O73860"},{"id":"T39","span":{"begin":72,"end":81},"obj":"Q6V115"},{"id":"T36","span":{"begin":72,"end":81},"obj":"D010047"},{"id":"T37","span":{"begin":72,"end":81},"obj":"D010047"},{"id":"T40","span":{"begin":82,"end":95},"obj":"GO:0046960"},{"id":"T44","span":{"begin":135,"end":145},"obj":"19831"},{"id":"T41","span":{"begin":135,"end":145},"obj":"CHEBI:3207"},{"id":"T42","span":{"begin":135,"end":145},"obj":"D019819"},{"id":"T43","span":{"begin":135,"end":145},"obj":"D019819"},{"id":"T48","span":{"begin":171,"end":183},"obj":"10438"},{"id":"T45","span":{"begin":171,"end":183},"obj":"D013806"},{"id":"T46","span":{"begin":171,"end":183},"obj":"D013806"},{"id":"T47","span":{"begin":171,"end":183},"obj":"CHEBI:28177"},{"id":"T52","span":{"begin":251,"end":261},"obj":"19831"},{"id":"T49","span":{"begin":251,"end":261},"obj":"CHEBI:3207"},{"id":"T50","span":{"begin":251,"end":261},"obj":"D019819"},{"id":"T51","span":{"begin":251,"end":261},"obj":"D019819"},{"id":"T56","span":{"begin":274,"end":286},"obj":"10438"},{"id":"T53","span":{"begin":274,"end":286},"obj":"D013806"},{"id":"T54","span":{"begin":274,"end":286},"obj":"D013806"},{"id":"T55","span":{"begin":274,"end":286},"obj":"CHEBI:28177"}],"text":"Separate groups of guinea pigs were treated during the course of 21-day ovalbumin sensitization with provinol (20 mg/kg/day, p.o.), or budesonide (1 mM by inhalation), or theophylline (10 mg/kg/day, i.p.), and with a half-dose combination of provinol+budesonide or provinol+theophylline."}

{"project":"Inflammaging","denotations":[{"id":"T4","span":{"begin":0,"end":287},"obj":"Sentence"},{"id":"T4","span":{"begin":0,"end":287},"obj":"Sentence"}],"text":"Separate groups of guinea pigs were treated during the course of 21-day ovalbumin sensitization with provinol (20 mg/kg/day, p.o.), or budesonide (1 mM by inhalation), or theophylline (10 mg/kg/day, i.p.), and with a half-dose combination of provinol+budesonide or provinol+theophylline."}